{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:19:44Z","timestamp":1790705984249,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Waardenburg syndrome (WS) is a rare genetic disorder. The purpose of this study was to investigate clinical and molecular characteristics of WS in four probands from four different Iranian families.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      The first patient was a 1-year-old symptomatic boy with congenital hearing loss and heterochromia iridis with a blue segment in his left iris. The second case was a 1.5-year-old symptomatic girl who manifested congenital profound hearing loss, brilliant blue eyes, and skin hypopigmentation on the abdominal region at birth time. The third patient was an 8-month-old symptomatic boy with developmental delay, mild atrophy, hypotonia, brilliant blue eyes, skin hypopigmentation on her hand and foot, Hirschsprung disease, and congenital profound hearing loss; the fourth patient was a 4-year-old symptomatic boy who showed dystopia canthorum, broad nasal root, synophrys, skin hypopigmentation on her hand and abdomen, brilliant blue eyes, and congenital profound hearing loss. Whole exome sequencing (WES) was used for each proband to identify the underlying genetic factor. Sanger sequencing was performed for validation of the identified mutations in probands and the available family members. A novel heterozygous frameshift mutation, c.996delT (p.K334Sfs*15), on exon 8 of the\n                      <jats:italic>MITF<\/jats:italic>\n                      gene was identified in the patient of the first family diagnosed with WS2A. Two novel\n                      <jats:italic>de novo<\/jats:italic>\n                      heterozygous mutations including a missense mutation, c.950G\u2009&gt;\u2009A (p.R317K), on exon 8 of the\n                      <jats:italic>MITF<\/jats:italic>\n                      gene, and a frameshift mutation, c.684delC (p.E229Sfs*57), on the exon 3 of the\n                      <jats:italic>SOX10<\/jats:italic>\n                      gene were detected in patients of the second and third families with WS2A and PCWH (Peripheral demyelinating neuropathy, Central dysmyelinating leukodystrophy, Waardenburg syndrome, Hirschsprung disease), respectively. A previously reported heterozygous frameshift mutation, c.1024_1040del AGCACGATTCCTTCCAA, (p.S342Pfs*62), on exon 7 of the\n                      <jats:italic>PAX3<\/jats:italic>\n                      gene was identified in the patient of the fourth family with WS1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An exact description of the mutations responsible for WS provides useful information to explain the molecular cause of clinical features of WS and contributes to better genetic counseling of WS patients and their families.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-021-02521-6","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T17:29:14Z","timestamp":1612805354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Four mutations in MITF, SOX10 and PAX3 genes were identified as genetic causes of waardenburg syndrome in four unrelated Iranian patients: case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Safoura","family":"Zardadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Rayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Hassani","family":"Doabsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliagha","family":"Alishiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Keramatipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynab Javanfekr","family":"Shahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Morovvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"issue":"3","key":"2521_CR1","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3892\/mmr.2016.4774","volume":"13","author":"Y Chen","year":"2016","unstructured":"Chen Y, Yang F, Zheng H, Zhou J, Zhu G, Hu P, et al. Clinical and genetic investigation of families with type II Waardenburg syndrome. Mol Med Rep. 2016;13(3):1983\u20138.","journal-title":"Mol Med Rep"},{"issue":"endothelin3","key":"2521_CR2","first-page":"7143458","volume":"2019","author":"W Li","year":"2019","unstructured":"Li W, Mei L, Chen H, Cai X, Liu Y, Men M, et al. New genotypes and phenotypes in patients with 3 subtypes of Waardenburg syndrome identified by diagnostic next-generation sequencing. Neural Plast. 2019;2019(endothelin3):7143458.","journal-title":"Neural Plast."},{"issue":"7","key":"2521_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/jhg.2017.30","volume":"62","author":"J Sun","year":"2017","unstructured":"Sun J, Hao Z, Luo H, He C, Mei L, Liu Y, et al. Functional analysis of a nonstop mutation in MITF gene identified in a patient with Waardenburg syndrome type 2. J Hum Genet. 2017;62(7):703\u20139. https:\/\/doi.org\/10.1038\/jhg.2017.30.","journal-title":"J Hum Genet."},{"issue":"1","key":"2521_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13256-018-1704-1","volume":"12","author":"L Haj Kassem","year":"2018","unstructured":"Haj Kassem L, Ahmado MF, Sheikh Alganameh M. A rare case of seven siblings with Waardenburg syndrome: A case report. J Med Case Rep. 2018;12(1):1\u20135.","journal-title":"J Med Case Rep."},{"issue":"4","key":"2521_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/humu.21211","volume":"31","author":"V Pingault","year":"2010","unstructured":"Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, Bondurand N. Review and update of mutations causing Waardenburg syndrome. Hum Mutat. 2010;31(4):391\u2013406.","journal-title":"Hum Mutat."},{"issue":"1","key":"2521_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ajmg.1320550123","volume":"55","author":"XZ Liu","year":"1995","unstructured":"Liu XZ, Newton VE, Read AP. Waardenburg syndrome type II: Phenotypic findings and diagnostic criteria. Am J Med Genet. 1995;55(1):95\u2013100.","journal-title":"Am J Med Genet"},{"issue":"5","key":"2521_CR7","first-page":"902","volume":"50","author":"LA Farrer","year":"1992","unstructured":"Farrer LA, Grundfast KM, Amos J, Arnos KS, Asher JH, Beighton P, et al. Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: First report of the WS consortium. Am J Hum Genet. 1992;50(5):902\u201313.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2521_CR8","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3892\/etm.2016.3042","volume":"11","author":"Y Shi","year":"2016","unstructured":"Shi Y, Li X, Ju D, Li Y, Zhang X, Zhang Y. A novel mutation of the MITF gene in a family with Waardenburg syndrome type 2: A case report. Exp Ther Med. 2016;11(4):1516\u20138.","journal-title":"Exp Ther Med"},{"issue":"2","key":"2521_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.mjafi.2012.02.017","volume":"69","author":"N Vichare","year":"2013","unstructured":"Vichare N, Bhargava N. Waardenburg syndrome: A rare case with bilateral congenital cataract: An unusual entity. Med J Armed Forces India. 2013;69(2):172\u20134.","journal-title":"Med J Armed Forces India"},{"issue":"13","key":"2521_CR10","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/hmg\/9.13.1907","volume":"9","author":"N Bondurand","year":"2000","unstructured":"Bondurand N, Pingault V, Goerich DE, Lemort N, Sock E, Le Caignec C, et al. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet. 2000;9(13):1907\u201317.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2521_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/hmg\/6.5.659","volume":"6","author":"R Morell","year":"1997","unstructured":"Morell R, Spritz RA, Ho L, Pierpont J, Guo W, Friedman TB, et al. Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA). Hum Mol Genet. 1997;6(5):659\u201364.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"2521_CR12","doi-asserted-by":"publisher","first-page":"e77149","DOI":"10.1371\/journal.pone.0077149","volume":"8","author":"S Yang","year":"2013","unstructured":"Yang S, Dai P, Liu X, Kang D, Zhang X, Yang W, et al. Genetic and phenotypic heterogeneity in Chinese patients with Waardenburg syndrome type II. PLoS One. 2013;8(10):e77149.","journal-title":"PLoS One."},{"issue":"1","key":"2521_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13741-019-0135-x","volume":"9","author":"TA Khan","year":"2020","unstructured":"Khan TA, Safdar CA, Zameer S, Khushdil A. Waardenburg-Shah syndrome (WS type IV): a rare case from Pakistan. Perioper Med. 2020;9(1):1\u20133.","journal-title":"Perioper Med"},{"issue":"4","key":"2521_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/cge.12631","volume":"89","author":"J Song","year":"2016","unstructured":"Song J, Feng Y, Acke FR, Coucke P, Vleminckx K, Dhooge IJ. Hearing loss in Waardenburg syndrome: A systematic review. Clin Genet. 2016;89(4):416\u201325.","journal-title":"Clin Genet"},{"issue":"January","key":"2521_CR15","first-page":"2015","volume":"3","author":"Y Yoshida","year":"2016","unstructured":"Yoshida Y, Doi R, Adachi K, Nanba E, Kodani I, Ryoke K. A novel PAX3 mutation in a Japanese boy with Waardenburg syndrome type 1. Hum Genome Var. 2016;3(January):2015\u20137.","journal-title":"Hum Genome Var"},{"issue":"July","key":"2521_CR16","first-page":"2022","volume":"18","author":"S Kapoor","year":"2012","unstructured":"Kapoor S, Bindu PS, Taly AB, Sinha S, Gayathri N, Vasantha Rani S, et al. Genetic analysis of an Indian family with members affected with Waardenburg syndrome and Duchenne muscular dystrophy. Mol Vis. 2012;18(July):2022\u201332.","journal-title":"Mol Vis"},{"issue":"8","key":"2521_CR17","first-page":"e3143","volume":"10","author":"M Nusrat","year":"2018","unstructured":"Nusrat M, Tariq MA, Aslam S, Zil-E-Ali A, Shahid M, Mahmood S. A case of Waardenburg-Shah syndrome type 4 presenting with bilateral homochromatic blue Irises from Pakistan. Cureus. 2018;10(8):e3143.","journal-title":"Cureus."},{"issue":"25","key":"2521_CR18","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1093\/hmg\/11.25.3231","volume":"11","author":"M S\u00e1nchez-Mart\u00edn","year":"2002","unstructured":"S\u00e1nchez-Mart\u00edn M, Rodr\u00edguez-Garc\u00eda A, P\u00e9rez-Losada J, Sagrera A, Read AP, S\u00e1nchez-Garc\u00eda I. SLUG (SNA12) deletions in patients with Waardenburg disease. Hum Mol Genet. 2002;11(25):3231\u20136.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2521_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29245\/2572-9411\/2017\/6.1118","volume":"2","author":"M Shelby","year":"2017","unstructured":"Shelby M. Waardenburg syndrome expression and penetrance. J Rare Dis Res Treat. 2017;2(6):31\u201340.","journal-title":"J Rare Dis Res Treat"},{"issue":"8","key":"2521_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/jmg.31.10.744","volume":"34","author":"AP Read","year":"1997","unstructured":"Read AP, Newton VE. Waardenburg syndrome. J Med Genet. 1997;34(8):656\u201365. https:\/\/doi.org\/10.1136\/jmg.31.10.744.","journal-title":"J Med Genet."},{"issue":"1","key":"2521_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0896-6273(01)00259-8","volume":"30","author":"ER Price","year":"2001","unstructured":"Price ER, Fisher DE. Sensorineural deafness and pigmentation genes: Melanocytes and the Mitf transcriptional network. Neuron. 2001;30(1):15\u20138.","journal-title":"Neuron"},{"issue":"2","key":"2521_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ajmg.a.36302","volume":"164","author":"RM Fern\u00e1ndez","year":"2014","unstructured":"Fern\u00e1ndez RM, N\u00fa\u00f1ez-Ramos R, Enguix-Riego MV, Rom\u00e1n-Rodr\u00edguez FJ, Gal\u00e1n-G\u00f3mez E, Blesa-S\u00e1nchez E, et al. Waardenburg syndrome type 4: Report of two new cases caused by SOX10 mutations in Spain. Am J Med Genet Part A. 2014;164(2):542\u20137.","journal-title":"Am J Med Genet Part A"},{"issue":"3","key":"2521_CR23","doi-asserted-by":"publisher","first-page":"e001917","DOI":"10.1136\/bmjopen-2012-001917","volume":"3","author":"G Wildhardt","year":"2013","unstructured":"Wildhardt G, Zirn B, Graul-Neumann LM, Wechtenbruch J, Suckf\u00fcll M, Buske A, et al. Spectrum of novel mutations found in waardenburg syndrome types 1 and 2: Implications for molecular genetic diagnostics. BMJ Open. 2013;3(3):e001917.","journal-title":"BMJ Open."},{"issue":"1","key":"2521_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbrc.2010.05.066","volume":"397","author":"H Chen","year":"2010","unstructured":"Chen H, Jiang L, Xie Z, Mei L, He C, Hu Z, et al. Novel mutations of PAX3, MITF, and SOX10 genes in Chinese patients with type I or type II Waardenburg syndrome. Biochem Biophys Res Commun. 2010;397(1):70\u20134. https:\/\/doi.org\/10.1016\/j.bbrc.2010.05.066.","journal-title":"Biochem Biophys Res Commun."},{"issue":"11","key":"2521_CR25","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/hmg\/4.11.2131","volume":"4","author":"M Tassabehji","year":"1995","unstructured":"Tassabehji M, Newton VE, Liu XZ, Brady A, Donnai D, Krajewska-walasek M, et al. The mutational spectrum in waardenburg syndrome. Hum Mol Genet. 1995;4(11):2131\u20137.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2521_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000476020","volume":"8","author":"N Jalilian","year":"2017","unstructured":"Jalilian N, Tabatabaiefar MA, Bahrami T, Karbasi G, Bahramian MH, Salimpoor A, et al. A novel pathogenic variant in the MITF gene segregating with a unique spectrum of ocular findings in an extended Iranian Waardenburg syndrome kindred. Mol Syndromol. 2017;8(4):195\u2013200.","journal-title":"Mol Syndromol"},{"issue":"1","key":"2521_CR27","first-page":"17","volume":"7","author":"N Jalilian","year":"2018","unstructured":"Jalilian N, Tabatabaiefar MA, Yazdanpanah M, Darabi E, Bahrami T, Zekri A, et al. A comprehensive genetic and clinical evaluation of Waardenburg syndrome type II in a set of Iranian patients. Int J Mol Cell Med. 2018;7(1):17\u201323.","journal-title":"Int J Mol Cell Med."},{"issue":"4","key":"2521_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1755-148X.2010.00711.x","volume":"23","author":"ML Harris","year":"2010","unstructured":"Harris ML, Baxter LL, Loftus SK, Pavan WJ. Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res. 2010;23(4):496\u2013513.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"2521_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ajmg.1320580205","volume":"58","author":"CT Baldwin","year":"1995","unstructured":"Baldwin CT, Hoth CF, Macina RA, Milunsky A. Mutations in PAX3 that cause Waardenburg syndrome type I: Ten new mutations and review of the literature. Am J Med Genet. 1995;58(2):115\u201322.","journal-title":"Am J Med Genet"},{"issue":"10","key":"2521_CR30","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.ijporl.2015.07.039","volume":"79","author":"N Jalilian","year":"2015","unstructured":"Jalilian N, Tabatabaiefar MA, Farhadi M, Bahrami T, Noori-Daloii MR. A novel mutation in the PAX3 gene causes Waardenburg syndrome type I in an Iranian family. Int J Pediatr Otorhinolaryngol. 2015;79(10):1736\u201340. https:\/\/doi.org\/10.1016\/j.ijporl.2015.07.039.","journal-title":"Int J Pediatr Otorhinolaryngol."},{"issue":"2","key":"2521_CR31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.gene.2015.08.023","volume":"574","author":"N Jalilian","year":"2015","unstructured":"Jalilian N, Tabatabaiefar MA, Farhadi M, Bahrami T, Emamdjomeh H, Noori-Daloii MR. Molecular and clinical characterization of Waardenburg syndrome type I in an Iranian cohort with two novel PAX3 mutations. Gene. 2015;574(2):302\u20137. https:\/\/doi.org\/10.1016\/j.gene.2015.08.023.","journal-title":"Gene."},{"issue":"12","key":"2521_CR32","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1002\/ajmg.a.37937","volume":"170","author":"V Cort\u00e9s-Gonz\u00e1lez","year":"2016","unstructured":"Cort\u00e9s-Gonz\u00e1lez V, Zenteno JC, Guzm\u00e1n-S\u00e1nchez M, Giordano-Herrera V, Guadarrama-Vallejo D, Ru\u00edz-Quintero N, et al. Tietz\/Waardenburg type 2A syndrome associated with posterior microphthalmos in two unrelated patients with novel MITF gene mutations. Am J Med Genet Part A. 2016;170(12):3294\u20137.","journal-title":"Am J Med Genet Part A."},{"issue":"February","key":"2521_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev.genet.38.072902.092717","volume":"38","author":"E Steingr\u00edmsson","year":"2004","unstructured":"Steingr\u00edmsson E, Copeland NG, Jenkins NA. Melanocytes and the Microphthalmia transcription factor network. Annu Rev Genet. 2004;38(February):365\u2013411.","journal-title":"Annu Rev Genet"},{"issue":"1","key":"2521_CR34","first-page":"76","volume":"59","author":"Y Nobukuni","year":"1996","unstructured":"Nobukuni Y, Watanabe A, Takeda K, Skarka H, Tachibana M. Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A. Am J Hum Genet. 1996;59(1):76\u201383.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2521_CR35","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1006\/bbrc.1998.8838","volume":"247","author":"S Amae","year":"1998","unstructured":"Amae S, Fuse N, Yasumoto KI, Sato S, Yajima I, Yamamoto H, et al. Identification of a novel isoform of microphthalmia-associated transcription factor that is enriched in retinal pigment epithelium. Biochem Biophys Res Commun. 1998;247(3):710\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2521_CR36","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00018-014-1791-0","volume":"72","author":"ML Hartman","year":"2015","unstructured":"Hartman ML, Czyz M. MITF in melanoma: Mechanisms behind its expression and activity. Cell Mol Life Sci. 2015;72(7):1249\u201360.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2521_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/hmg\/9.1.125","volume":"9","author":"K Takeda","year":"2000","unstructured":"Takeda K, Takemoto C, Kobayashi I, Watanabe A, Nobukuni Y, Fisher DE, et al. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum Mol Genet. 2000;9(1):125\u201332.","journal-title":"Hum Mol Genet"},{"issue":"21","key":"2521_CR38","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1093\/hmg\/ddt285","volume":"22","author":"C Grill","year":"2013","unstructured":"Grill C, Bergsteinsd\u00f3 ttir K, \u00d6gmundsd\u00f3 ttir MH, Pogenberg V, Schepsky A, Wilmanns M, et al. MITF mutations associated with pigment deficiency syndromes and melanoma have different effects on protein function. Hum Mol Genet. 2013;22(21):4357\u201367.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2521_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jgg.2011.11.003","volume":"38","author":"X Yan","year":"2011","unstructured":"Yan X, Zhang T, Wang Z, Jiang Y, Chen Y, Wang H, et al. A novel mutation in the MITF may be digenic with GJB2 mutations in a large Chinese family of Waardenburg syndrome type II. J Genet Genomics. 2011;38(12):585\u201391. https:\/\/doi.org\/10.1016\/j.jgg.2011.11.003.","journal-title":"J Genet Genomics."},{"issue":"3","key":"2521_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mgg3.1128","volume":"8","author":"S Ren","year":"2020","unstructured":"Ren S, Chen X, Kong X, Chen Y, Wu Q, Jiao Z, et al. Identification of six novel variants in Waardenburg syndrome type II by next-generation sequencing. Mol Genet Genomic Med. 2020;8(3):1\u20138.","journal-title":"Mol Genet Genomic Med"},{"issue":"6","key":"2521_CR41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/labinvest.2017.9","volume":"97","author":"A Kawakami","year":"2017","unstructured":"Kawakami A, Fisher DE. The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology. Lab Investig. 2017;97(6):649\u201356. https:\/\/doi.org\/10.1038\/labinvest.2017.9.","journal-title":"Lab Investig."},{"issue":"1\u20133","key":"2521_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0167-4781(00)00051-8","volume":"1491","author":"T Udono","year":"2000","unstructured":"Udono T, Yasumoto KI, Takeda K, Amae S, Watanabe KI, Saito H, et al. Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters. Biochim Biophys Acta - Gene Struct Expr. 2000;1491(1\u20133):205\u201319.","journal-title":"Biochim Biophys Acta - Gene Struct Expr"},{"issue":"1","key":"2521_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.0022-202x.2001.00010.x","volume":"6","author":"S Shibahara","year":"2001","unstructured":"Shibahara S. Microphthalmia-associated transcription factor (MITF): Multiplicity in structure, function, and regulation. J Investig Dermatology Symp Proc. 2001;6(1):99\u2013104. https:\/\/doi.org\/10.1046\/j.0022-202x.2001.00010.x.","journal-title":"J Investig Dermatology Symp Proc."},{"issue":"5","key":"2521_CR44","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/ejhg.2011.234","volume":"20","author":"S L\u00e9ger","year":"2012","unstructured":"L\u00e9ger S, Balguerie X, Goldenberg A, Drouin-Garraud V, Cabot A, Amstutz-Montadert I, et al. Novel and recurrent non-truncating mutations of the MITF basic domain: Genotypic and phenotypic variations in Waardenburg and Tietz syndromes. Eur J Hum Genet. 2012;20(5):584\u20137.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"2521_CR45","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ajhg.2016.11.004","volume":"99","author":"A George","year":"2016","unstructured":"George A, Zand DJ, Hufnagel RB, Sharma R, Sergeev YV, Legare JM, et al. Biallelic mutations in MITF cause Coloboma, Osteopetrosis, Microphthalmia, Macrocephaly, Albinism, and Deafness. Am J Hum Genet. 2016;99(6):1388\u201394. https:\/\/doi.org\/10.1016\/j.ajhg.2016.11.004.","journal-title":"Am J Hum Genet."},{"issue":"24","key":"2521_CR46","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1093\/hmg\/10.24.2783","volume":"10","author":"N Bondurand","year":"2001","unstructured":"Bondurand N, Girard M, Pingault V, Lemort N, Dubourg O, Goossens M. Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet. 2001;10(24):2783\u201395.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2521_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12887-018-1139-2","volume":"18","author":"N Suzuki","year":"2018","unstructured":"Suzuki N, Mutai H, Miya F, Tsunoda T, Terashima H, Morimoto N, et al. A case report of reversible generalized seizures in a patient with Waardenburg syndrome associated with a novel nonsense mutation in the penultimate exon of SOX10. BMC Pediatr. 2018;18(1):2\u20135.","journal-title":"BMC Pediatr"},{"issue":"5","key":"2521_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mgg3.1217","volume":"8","author":"Y Yu","year":"2020","unstructured":"Yu Y, Liu W, Chen M, Yang Y, Yang Y, Hong E, et al. Two novel mutations of PAX3 and SOX10 were characterized as genetic causes of Waardenburg syndrome. Mol Genet Genomic Med. 2020;8(5):1\u20138.","journal-title":"Mol Genet Genomic Med"},{"issue":"6","key":"2521_CR49","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1086\/522090","volume":"81","author":"N Bondurand","year":"2007","unstructured":"Bondurand N, Dastot-Le Moal F, Stanchina L, Collot N, Baral V, Marlin S, et al. Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet. 2007;81(6):1169\u201385.","journal-title":"Am J Hum Genet"},{"issue":"6A","key":"2521_CR50","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1111\/j.1582-4934.2008.00427.x","volume":"12","author":"Q Wang","year":"2008","unstructured":"Wang Q, Fang WH, Krupinski J, Kumar S, Slevin M, Kumar P. Pax genes in embryogenesis and oncogenesis. Genes J Cell Mol Med. 2008;12(6A):2281\u201394.","journal-title":"Genes J Cell Mol Med"},{"issue":"May","key":"2521_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.gene.2018.04.087","volume":"666","author":"S Boudjadi","year":"2018","unstructured":"Boudjadi S, Chatterjee B, Sun W, Vemu P, Barr FG. The expression and function of PAX3 in development and disease. Gene. 2018;666(May):145\u201357. https:\/\/doi.org\/10.1016\/j.gene.2018.04.087.","journal-title":"Gene."},{"issue":"3","key":"2521_CR52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng1194-251","volume":"8","author":"M Tassabehji","year":"1994","unstructured":"Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet. 1994;8(3):251\u20135 http:\/\/www.nature.com\/articles\/ng1194-251.","journal-title":"Nat Genet."},{"issue":"1","key":"2521_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12886-016-0181-9","volume":"18","author":"EY Choi","year":"2018","unstructured":"Choi EY, Choi W, Lee CS. A novel PAX3 mutation in a Korean patient with Waardenburg syndrome type 1 and unilateral branch retinal vein and artery occlusion: A case report 11 Medical and Health Sciences 1113 Ophthalmology and Optometry. BMC Ophthalmol. 2018;18(1):4\u20139.","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"2521_CR54","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02521-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-02521-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02521-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T22:04:25Z","timestamp":1674943465000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-02521-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2521"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-02521-6","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"10 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethical committees of Rasad Pathobiology and Genetic Laboratory, Tehran, Iran. Written informed consent to participate was obtained from the patients\u2019 parents and all participants (family members who underwent genetics testing etc.) of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients\u2019 parents and all participants (family members who underwent genetics testing) for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interest in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}